ClinicalTrials.Veeva

Menu

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Allergan logo

Allergan

Status and phase

Completed
Phase 3

Conditions

Dry Eye Syndromes

Treatments

Drug: Genteal® Lubricant Gel Drops
Drug: Carboxymethylcellulose Sodium Based Eye Drops
Drug: Systane® Gel Drops

Study type

Interventional

Funder types

Industry

Identifiers

NCT02455050
11193X-002

Details and patient eligibility

About

A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.

Enrollment

79 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Current use of an artificial tear product
  • Visual Acuity of at least 20/40 (while wearing glasses, if necessary).

Exclusion criteria

  • Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
  • Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months
  • Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months
  • Diagnosis of glaucoma.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

79 participants in 4 patient groups

New Eye Drop Formulation then Systane®
Other group
Description:
1 to 2 drops of New Eye Drop Formulation (carboxymethylcellulose sodium based eye drops) in each eye as needed at least 2 times daily for 2 weeks followed by 1 to 2 drops of Systane® Gel Drops in each eye as needed at least 2 times daily for 2 weeks.
Treatment:
Drug: Systane® Gel Drops
Drug: Carboxymethylcellulose Sodium Based Eye Drops
Systane® then New Eye Drop Formulation
Other group
Description:
1 to 2 drops of Systane® Gel Drops in each eye as needed at least 2 times daily for 2 weeks followed by 1 to 2 drops of New Eye Drop Formulation (carboxymethylcellulose sodium based eye drops) in each eye as needed at least 2 times daily for 2 weeks.
Treatment:
Drug: Systane® Gel Drops
Drug: Carboxymethylcellulose Sodium Based Eye Drops
Genteal® then New Eye Drop Formulation
Other group
Description:
1 to 2 drops of Genteal® Lubricant Gel Drops in each eye as needed at least 2 times daily for 2 weeks followed 1 to 2 drops of New Eye Drop Formulation (carboxymethylcellulose sodium based eye drops) in each eye as needed at least 2 times daily for 2 weeks.
Treatment:
Drug: Carboxymethylcellulose Sodium Based Eye Drops
Drug: Genteal® Lubricant Gel Drops
New Eye Drop Formulation then Genteal®
Other group
Description:
1 to 2 drops of New Eye Drop Formulation (carboxymethylcellulose sodium based eye drops) in each eye as needed at least 2 times daily for 2 weeks followed by 1 to 2 drops of Genteal® Lubricant Gel Drops in each eye as needed at least 2 times daily for 2 weeks.
Treatment:
Drug: Carboxymethylcellulose Sodium Based Eye Drops
Drug: Genteal® Lubricant Gel Drops

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems